Concepedia

KIMBERLY D. MCBRIEN

KD

Statistics

Publications

5

Citations

234

H-Index

5

Active since

1995

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

Instytut Farmaceutyczny

KIMBERLY D. MCBRIEN is an author at Bristol-Myers Squibb (United States) specializing in life sciences, drug discovery, and fungal secondary metabolites.

Publications per year

1995–1998

5

Publications

5

Rakicidins, New Cytotoxic Lipopeptides from Micromonospora sp. Fermentation, Isolation and Characterization.

KIMBERLY D. MCBRIEN, Ronald L. Berry, Susan E. Lowe et al. · The Journal of Antibiotics · 1995 · 95 citations · Full text

, , +11

Fusaricide, a New Cytotoxic <i>N</i>-Hydroxypyridone from <i>Fusarium </i>sp.

KIMBERLY D. MCBRIEN, Qi Gao, Stella Huang et al. · Journal of Natural Products · 1996 · 56 citations

, , +4

BMS-182123, a Fungal Metabolite that Inhibits the Production of TNF-.ALPHA. by Macrophages and Monocytes.

Glenn A. Warr, Judith A. Veitch, Ann W. Walsh et al. · The Journal of Antibiotics · 1996 · 51 citations

, , +12

Ascosteroside, a New Antifungal Agent from Ascotricha amphitricha. II. Isolation and Structure Elucidation.

John E. Leet, Stella Huang, Steven E. Klohr et al. · The Journal of Antibiotics · 1996 · 19 citations · Full text

, , +10

Quanolirones I and II, Two New Human Cytomegalovirus Protease Inhibitors Produced by <i>Streptomyces</i> sp. WC76535

Jingfang Qian‐Cutrone, Janet M. Kolb, KIMBERLY D. MCBRIEN et al. · Journal of Natural Products · 1998 · 13 citations

, , +5

1–5 of 5